Local news
Raleigh News Hub
Curated local headlines with AI summaries and a practical FinTechful perspective.
14 stories
Latest News
14 Total
Trump administration finalizes new standards for independent contractors
The Trump administration has finalized new standards regarding independent contractors, which will impact how companies classify their workers. These changes aim to provide clarity for businesses navigating labor regulations. Companies should review the new guidelines to ensure compliance and understand the implications for their workforce.

The SEC aims to transform how companies report executive pay and perks
The SEC has proposed significant changes to the reporting requirements for executive pay and perks, marking the first major update in two decades. This initiative aims to enhance transparency in how publicly traded companies disclose compensation for their executives.

Raleigh council member pushes for MLB as big decisions loom
A Raleigh City Council member is advocating for the introduction of a Major League Baseball franchise, citing potential boosts to regional tax revenue. This push comes amid ongoing discussions and concerns raised by leadership at UNC regarding the implications of such a move.

$14 million downtown redevelopment planned in fast-growing North Carolina town
A redevelopment project worth $14 million is set to transform a long-vacant property in a rapidly growing North Carolina town. The initiative aims to revitalize the area and address the blight that has persisted for nearly four decades.

NCDOT grapples with aging infrastructure as population growth strains Triangle roads
North Carolina's transportation agency is under increasing pressure to update its aging infrastructure due to significant population growth in the Triangle area. The NCDOT is tasked with addressing the changing travel patterns and demands that come with this demographic shift.

Durham-made gene therapy under FDA investigation over tumor reports
The FDA is investigating a gene therapy developed in Durham after reports of tumors in a small number of infant patients who received the treatment. This therapy is associated with a significant revenue stream for the company involved. The outcome of the investigation may impact future use and development of the therapy.